Department of Medicine, Division of Cardiology (J.C.-T., W.W., A.B., C.T., B.M., S.C., J.E.C., D.P.J., H.T., H.C., C.A.J.), Johns Hopkins Hospital, Baltimore, MD.
Cardiovascular Genetics Center, Montreal Heart Institute, Université de Montréal, Canada (J.C.-T., R.T., A.A., M.T., L.R., P.K.).
Circ Arrhythm Electrophysiol. 2021 Jan;14(1):e008509. doi: 10.1161/CIRCEP.120.008509. Epub 2020 Dec 9.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with ventricular arrhythmias (VA) and sudden cardiac death (SCD). A model was recently developed to predict incident sustained VA in patients with ARVC. However, since this outcome may overestimate the risk for SCD, we aimed to specifically predict life-threatening VA (LTVA) as a closer surrogate for SCD.
We assembled a retrospective cohort of definite ARVC cases from 15 centers in North America and Europe. Association of 8 prespecified clinical predictors with LTVA (SCD, aborted SCD, sustained, or implantable cardioverter-defibrillator treated ventricular tachycardia >250 beats per minute) in follow-up was assessed by Cox regression with backward selection. Candidate variables included age, sex, prior sustained VA (≥30s, hemodynamically unstable, or implantable cardioverter-defibrillator treated ventricular tachycardia; or aborted SCD), syncope, 24-hour premature ventricular complexes count, the number of anterior and inferior leads with T-wave inversion, left and right ventricular ejection fraction. The resulting model was internally validated using bootstrapping.
A total of 864 patients with definite ARVC (40±16 years; 53% male) were included. Over 5.75 years (interquartile range, 2.77-10.58) of follow-up, 93 (10.8%) patients experienced LTVA including 15 with SCD/aborted SCD (1.7%). Of the 8 prespecified clinical predictors, only 4 (younger age, male sex, premature ventricular complex count, and number of leads with T-wave inversion) were associated with LTVA. Notably, prior sustained VA did not predict subsequent LTVA (=0.850). A model including only these 4 predictors had an optimism-corrected C-index of 0.74 (95% CI, 0.69-0.80) and calibration slope of 0.95 (95% CI, 0.94-0.98) indicating minimal over-optimism.
LTVA events in patients with ARVC can be predicted by a novel simple prediction model using only 4 clinical predictors. Prior sustained VA and the extent of functional heart disease are not associated with subsequent LTVA events.
致心律失常性右室心肌病(ARVC)与室性心律失常(VA)和心源性猝死(SCD)有关。最近开发了一种模型来预测 ARVC 患者持续性 VA 的发生。然而,由于这种结果可能高估 SCD 的风险,我们旨在专门预测危及生命的 VA(LTVA),作为 SCD 的更接近替代指标。
我们汇集了来自北美和欧洲 15 个中心的明确 ARVC 病例的回顾性队列。通过向后选择的 Cox 回归评估 8 个预设临床预测因子与随访中的 LTVA(SCD、SCD 未遂、持续性或植入式心律转复除颤器治疗的室性心动过速>250 次/分钟)之间的关联。候选变量包括年龄、性别、既往持续性 VA(≥30 秒、血流动力学不稳定或植入式心律转复除颤器治疗的室性心动过速;或 SCD 未遂)、晕厥、24 小时室性期前收缩计数、T 波倒置的前导和下导数量、左室和右室射血分数。使用自举法对得到的模型进行内部验证。
共有 864 例明确 ARVC 患者(40±16 岁;53%为男性)入组。在 5.75 年(四分位距,2.77-10.58)的随访中,93(10.8%)例患者发生 LTVA,其中 15 例发生 SCD/未遂 SCD(1.7%)。在 8 个预设的临床预测因子中,只有 4 个(年龄较小、男性、室性期前收缩计数和 T 波倒置导联数量)与 LTVA 相关。值得注意的是,既往持续性 VA 与随后的 LTVA 无关(=0.850)。仅包含这 4 个预测因子的模型具有经矫正后乐观性的 C 指数为 0.74(95%CI,0.69-0.80)和校准斜率为 0.95(95%CI,0.94-0.98),表明轻度过度乐观。
使用仅 4 个临床预测因子的新型简单预测模型可预测 ARVC 患者的 LTVA 事件。既往持续性 VA 和功能性心脏病的严重程度与随后的 LTVA 事件无关。